Tag Archives: finance policy

GEN’s “Top 10” Session Picks for the 2014 BIO International Convention

John Sterling

The following article, reproduced in full below, was originally published at Genetic Engineering & Biotechnology News. It’s been a “hot” year for biotech! As G. Steven Burrill, CEO of Burrill & Co., noted in a recent report, life science firms raised $2.9 billion in new equity capital globally from public investors in February. This included $1.1 billion raised by 18 companies that completed initial public offerings and $1.8 billion raised by 23 companies that completed Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Debt, Taxes and Politics: Is There a Way Out?

Debt, Taxes and Politics: Is There a Way Out?

BIO President and CEO Jim Greenwood kicked off a keynote discussion with Sen. Alan Simpson and Erskine Bowles at the BIO International Convention, saying public policy can make or break the biotech industry’s best efforts to deliver innovations that make our world a better place, and then asked the esteemed duo if our government can make the tough choices needed to keep our economy strong. “You can’t tax your way out of this hole, you can’t cut spending your Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

The Justness of Gene Patents

The Justness of Gene Patents

Most of the biotechnology world awaits the U.S. Supreme Court’s answer to the Question Presented, “Are human genes patentable,” in the Association of Molecular Pathologists et al. v. Myriad Genetics case. Claims to “human genes” have a canonical form that has been developed over the thirty years during which “genes” (human or otherwise) have been patented under U.S. law: An isolated nucleic acid having a nucleotide sequence that encodes a protein having an amino acid Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , ,

Governors Share Best Practices on Bringing Biotech Jobs to their States

Governors

With the state competition for biotech jobs in full force at the BIO International Convention, BIO released its Bioscience Economic Development report yesterday to a standing room only crowd that came to hear Texas Gov. Rick Perry, Pennsylvania Gov. Tom Corbett, Missouri Gov. Jay Nixon and Director of Illinois Department of Commerce and Economic Opportunity Jack Lavin share their insights on attracting and growing the biotech industry within their states. Common themes quickly emerged around Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Patent Utility Requirements for Biopharmaceutical Inventions: How Much is Enough?

Credit: Andrea Sivarsson

A debate between the innovative and generic perspectives on pharmaceutical patent law in Canada, moderated by David Kappos, will be held in Chicago on Monday April 22nd from 2:30-3:30pm in room S404A at this year’s BIO International Convention. Former Undersecretary of Commerce for Intellectual Property and USPTO Director David J. Kappos will moderate a panel of legal experts who will discuss recent developments in the area of patent utility and its implications for biopharmaceutical innovation.  Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , ,